Dr Reddy’s hit by a big recall in the US
The FDA flags manufacturing issues in multiple strengths of Cinacalcet tablets produced by the pharma major in India.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Business
You may also like
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Will changes to the H-1B visa programme adversely impact Indian IT firms?
Contrary to popular perception, any tinkering with the H-1B visa process may not hit local companies hard and may actually end up driving more jobs to India.
With US nod, UAE scores a big win for advanced AI chips
By green-lighting the export of advanced AI chips to a Microsoft-run facility in the UAE, the US has scored a massive advantage in its tech race against China.
